230 related articles for article (PubMed ID: 28218273)
1. Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening.
Temml V; Garscha U; Romp E; Schubert G; Gerstmeier J; Kutil Z; Matuszczak B; Waltenberger B; Stuppner H; Werz O; Schuster D
Sci Rep; 2017 Feb; 7():42751. PubMed ID: 28218273
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase.
Garscha U; Romp E; Pace S; Rossi A; Temml V; Schuster D; König S; Gerstmeier J; Liening S; Werner M; Atze H; Wittmann S; Weinigel C; Rummler S; Scriba GK; Sautebin L; Werz O
Sci Rep; 2017 Aug; 7(1):9398. PubMed ID: 28839250
[TBL] [Abstract][Full Text] [Related]
3. 4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP).
Banoglu E; Çelikoğlu E; Völker S; Olgaç A; Gerstmeier J; Garscha U; Çalışkan B; Schubert US; Carotti A; Macchiarulo A; Werz O
Eur J Med Chem; 2016 May; 113():1-10. PubMed ID: 26922224
[TBL] [Abstract][Full Text] [Related]
4. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O
Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening.
Waltenberger B; Garscha U; Temml V; Liers J; Werz O; Schuster D; Stuppner H
J Chem Inf Model; 2016 Apr; 56(4):747-62. PubMed ID: 26882208
[TBL] [Abstract][Full Text] [Related]
6. Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents.
Werz O; Gerstmeier J; Garscha U
Expert Opin Ther Pat; 2017 May; 27(5):607-620. PubMed ID: 28005436
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis.
Gür ZT; Çalışkan B; Banoglu E
Eur J Med Chem; 2018 Jun; 153():34-48. PubMed ID: 28784429
[TBL] [Abstract][Full Text] [Related]
8. The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP).
Pergola C; Gerstmeier J; Mönch B; Çalışkan B; Luderer S; Weinigel C; Barz D; Maczewsky J; Pace S; Rossi A; Sautebin L; Banoglu E; Werz O
Br J Pharmacol; 2014 Jun; 171(12):3051-64. PubMed ID: 24641614
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP).
Banoglu E; Çalişkan B; Luderer S; Eren G; Özkan Y; Altenhofen W; Weinigel C; Barz D; Gerstmeier J; Pergola C; Werz O
Bioorg Med Chem; 2012 Jun; 20(12):3728-41. PubMed ID: 22607880
[TBL] [Abstract][Full Text] [Related]
10. Novel thiazolopyridine derivatives of diflapolin as dual sEH/FLAP inhibitors with improved solubility.
Schoenthaler M; Waltl L; Hasenoehrl T; Seher D; Lutz A; Aulinger L; Temml V; König S; Siller A; Braun DE; Garscha U; Werz O; Schuster D; Schennach H; Koeberle A; Matuszczak B
Bioorg Chem; 2023 Oct; 139():106685. PubMed ID: 37418786
[TBL] [Abstract][Full Text] [Related]
11. Identification of selective 5-LOX and FLAP inhibitors as novel anti-inflammatory agents by ligand-based virtual screening.
Cerchia C; Küfner L; Werz O; Lavecchia A
Eur J Med Chem; 2024 Jan; 263():115932. PubMed ID: 37976708
[TBL] [Abstract][Full Text] [Related]
12. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
Das Mahapatra A; Choubey R; Datta B
Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors by Exploiting a Multistep Virtual Screening Protocol.
Olgac A; Carotti A; Kretzer C; Zergiebel S; Seeling A; Garscha U; Werz O; Macchiarulo A; Banoglu E
J Chem Inf Model; 2020 Mar; 60(3):1737-1748. PubMed ID: 32045233
[TBL] [Abstract][Full Text] [Related]
14. Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP).
Ho JD; Lee MR; Rauch CT; Aznavour K; Park JS; Luz JG; Antonysamy S; Condon B; Maletic M; Zhang A; Hickey MJ; Hughes NE; Chandrasekhar S; Sloan AV; Gooding K; Harvey A; Yu XP; Kahl SD; Norman BH
Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129800. PubMed ID: 33246032
[TBL] [Abstract][Full Text] [Related]
15. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S
Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase.
Meirer K; Glatzel D; Kretschmer S; Wittmann SK; Hartmann M; Blöcher R; Angioni C; Geisslinger G; Steinhilber D; Hofmann B; Fürst R; Proschak E
Molecules; 2016 Dec; 22(1):. PubMed ID: 28036068
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model.
Liu JY; Yang J; Inceoglu B; Qiu H; Ulu A; Hwang SH; Chiamvimonvat N; Hammock BD
Biochem Pharmacol; 2010 Mar; 79(6):880-7. PubMed ID: 19896470
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of C(5)-substituted derivatives of leukotriene biosynthesis inhibitor BRP-7.
Levent S; Gerstmeier J; Olgaç A; Nikels F; Garscha U; Carotti A; Macchiarulo A; Werz O; Banoglu E; Çalışkan B
Eur J Med Chem; 2016 Oct; 122():510-519. PubMed ID: 27423639
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screening.
Moser D; Achenbach J; Klingler FM; Estel la B; Hahn S; Proschak E
Bioorg Med Chem Lett; 2012 Nov; 22(21):6762-5. PubMed ID: 23017883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
